{"id":"W1984252859","doi":"10.1158/0008-5472.sabcs13-p6-10-03","title":"Abstract P6-10-03: Comparative efficacy of everolimus in combination with exemestane and chemotherapy for advanced breast cancer in terms of progression-free survival","year":2013,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Everolimus; Medicine; Exemestane; Oncology; Internal medicine; Breast cancer; Randomized controlled trial; Progression-free survival; Hazard ratio; Cancer; Meta-analysis; Chemotherapy; Tamoxifen; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009367513,0.001455963,0.008795847,0.003432444,0.0003211293,0.002757886,0.0009968256,0.001804704,0.01027514],"category_scores_gemma":[0.01583227,0.0005503406,0.01704973,0.003397746,0.000673574,0.001414686,0.0009996864,0.001663213,0.0006285393],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001932125,"about_ca_system_score_gemma":0.002369994,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001904827,"about_ca_topic_score_gemma":0.004101185,"domain_scores_codex":[0.9922098,0.00450088,0.001907738,0.0004467049,0.0008165489,0.0001183908],"domain_scores_gemma":[0.9891232,0.006637381,0.002859005,0.0001917366,0.0009641311,0.0002245848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.06688211,0.0002608065,0.001678064,0.6111988,0.2808526,0.0001765655,0.00008874538,0.0005039169,0.00176844,0.0004194698,0.001104912,0.03506551],"study_design_scores_gemma":[0.05750718,0.009950298,0.01047739,0.07061619,0.8401352,0.0002954306,0.0001537225,0.0006629882,0.0007758891,0.0006754271,0.008689177,0.0000610316],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.03426907,0.9540932,0.0009252393,0.0008411495,0.0008255747,0.003588341,0.00271839,0.00006548292,0.002673497],"genre_scores_gemma":[0.5111336,0.4715317,0.004438887,0.001845119,0.00118065,0.005405964,0.002334129,0.00005203997,0.002077916],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01027514,"threshold_uncertainty_score":0.0495407,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05116332335270693,"score_gpt":0.4282500882082477,"score_spread":0.3770867648555408,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}